Literature DB >> 24019435

Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen.

Cédric B Chesnais1, François Missamou, Sébastien D S Pion, Jean Bopda, Frédéric Louya, Andrew C Majewski, Gary J Weil, Michel Boussinesq.   

Abstract

Abstract. The value of a semi-quantitative scoring of the filarial antigen test (Binax Now Filariasis card test, ICT) results was evaluated during a field survey in the Republic of Congo. One hundred and thirty-four (134) of 774 tests (17.3%) were clearly positive and were scored 1, 2, or 3; and 11 (1.4%) had questionable results. Wuchereria bancrofti microfilariae (mf) were detected in 41 of those 133 individuals with an ICT test score ≥ 1 who also had a night blood smear; none of the 11 individuals with questionable ICT results harbored night mf. Cuzick's test showed a significant trend for higher microfilarial densities in groups with higher ICT scores (P < 0.001). The ICT scores were also significantly correlated with blood mf counts. Because filarial antigen levels provide an indication of adult worm infection intensity, our results suggest that semi-quantitative reading of the ICT may be useful for grading the intensity of filarial infections in individuals and populations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24019435      PMCID: PMC3820335          DOI: 10.4269/ajtmh.13-0245

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  22 in total

1.  Evaluation of the whole blood filariasis ICT test for short-term monitoring after antifilarial treatment.

Authors:  A Schuetz; D G Addiss; M L Eberhard; P J Lammie
Journal:  Am J Trop Med Hyg       Date:  2000-04       Impact factor: 2.345

2.  Filaria dance sign and subclinical hydrocoele in two east African communities with bancroftian filariasis.

Authors:  Paul E Simonsen; Peter Bernhard; Walter G Jaoko; Dan W Meyrowitsch; Mwele N Malecela-Lazaro; Pascal Magnussen; Edwin Michael
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 Nov-Dec       Impact factor: 2.184

3.  A mathematical analysis of various factors involved in transmission of bancroftian filariasis in Pondicherry.

Authors:  P Vanamail; S Subramanian; P K Rajagopalan
Journal:  Indian J Med Res       Date:  1990-07       Impact factor: 2.375

4.  A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis.

Authors:  S J More; D B Copeman
Journal:  Trop Med Parasitol       Date:  1990-12

5.  A Wilcoxon-type test for trend.

Authors:  J Cuzick
Journal:  Stat Med       Date:  1985 Jan-Mar       Impact factor: 2.373

6.  Evaluation of a monoclonal-antibody based antigen assay for diagnosis of Wuchereria bancrofti infection in Egypt.

Authors:  R M Ramzy; A M Gad; R Faris; G J Weil
Journal:  Am J Trop Med Hyg       Date:  1991-06       Impact factor: 2.345

7.  A monoclonal antibody-based enzyme immunoassay for detecting parasite antigenemia in bancroftian filariasis.

Authors:  G J Weil; D C Jain; S Santhanam; A Malhotra; H Kumar; K V Sethumadhavan; F Liftis; T K Ghosh
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

8.  Og4C3 circulating antigen: a marker of infection and adult worm burden in Wuchereria bancrofti filariasis.

Authors:  S Chanteau; J P Moulia-Pelat; P Glaziou; N L Nguyen; P Luquiaud; C Plichart; P M Martin; J L Cartel
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

Review 9.  Diagnosis of human filariases (except onchocerciasis).

Authors:  Michael Walther; Ralph Muller
Journal:  Adv Parasitol       Date:  2003       Impact factor: 3.870

10.  Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood.

Authors:  Gary J Weil; Kurt C Curtis; Lawrence Fakoli; Kerstin Fischer; Lincoln Gankpala; Patrick J Lammie; Andrew C Majewski; Sonia Pelletreau; Kimberly Y Won; Fatorma K Bolay; Peter U Fischer
Journal:  Am J Trop Med Hyg       Date:  2013-05-20       Impact factor: 2.345

View more
  15 in total

1.  Molecular xenomonitoring (MX) and transmission assessment survey (TAS) of lymphatic filariasis elimination in two villages, Menoufyia Governorate, Egypt.

Authors:  M A Moustafa; M M I Salamah; H S Thabet; R A Tawfik; M M Mehrez; D M Hamdy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-02       Impact factor: 3.267

2.  The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo.

Authors:  Sébastien D S Pion; Cédric B Chesnais; Jean Bopda; Frédéric Louya; Peter U Fischer; Andrew C Majewski; Gary J Weil; Michel Boussinesq; François Missamou
Journal:  Am J Trop Med Hyg       Date:  2015-03-09       Impact factor: 2.345

3.  Evaluation of lymphatic filariasis in endemic area of Brazil where mass drug administration is not required.

Authors:  Ellyda Silva; Amanda Xavier; Elis Silva; Walter Barbosa Júnior; Abraham Rocha; Vania Freitas; Paula Oliveira; Ana Maria Aguiar-Santos; Cristine Bonfim; Zulma Medeiros
Journal:  Pathog Glob Health       Date:  2019-05-29       Impact factor: 3.735

4.  Positivity of Antigen Tests Used for Diagnosis of Lymphatic Filariasis in Individuals Without Wuchereria bancrofti Infection But with High Loa loa Microfilaremia.

Authors:  Sébastien D Pion; Céline Montavon; Cédric B Chesnais; Joseph Kamgno; Samuel Wanji; Amy D Klion; Thomas B Nutman; Michel Boussinesq
Journal:  Am J Trop Med Hyg       Date:  2016-10-10       Impact factor: 2.345

5.  Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania.

Authors:  Patrizia Amelio; Damien Portevin; Klaus Reither; Francis Mhimbira; Maxmillian Mpina; Anneth Tumbo; Beatrice Nickel; Hanspeter Marti; Stefanie Knopp; Song Ding; Adam Penn-Nicholson; Fatoumatta Darboe; Khalid Ohmiti; Thomas J Scriba; Giuseppe Pantaleo; Claudia Daubenberger; Matthieu Perreau
Journal:  PLoS Negl Trop Dis       Date:  2017-07-31

6.  Measurement of Circulating Filarial Antigen Levels in Human Blood with a Point-of-Care Test Strip and a Portable Spectrodensitometer.

Authors:  Cédric B Chesnais; Johnny Vlaminck; Billy Kunyu-Shako; Sébastien D Pion; Naomi-Pitchouna Awaca-Uvon; Gary J Weil; Dieudonné Mumba; Michel Boussinesq
Journal:  Am J Trop Med Hyg       Date:  2016-04-25       Impact factor: 2.345

7.  A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa.

Authors:  Cédric B Chesnais; Naomi-Pitchouna Awaca-Uvon; Fatoma K Bolay; Michel Boussinesq; Peter U Fischer; Lincoln Gankpala; Aboulaye Meite; François Missamou; Sébastien D Pion; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2017-09-11

8.  Chiluria in a lymphatic filariasis endemic area.

Authors:  Paulo Sérgio Ramos de Araújo; Valter Romão de Souza Junior; Anderson de Souza; Luciana de Barros Correia Fontes; Eduardo Brandao; Abraham Rocha
Journal:  BMC Res Notes       Date:  2018-05-02

9.  Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.

Authors:  Christine L Dubray; Anita D Sircar; Valery Madsen Beau de Rochars; Joshua Bogus; Abdel N Direny; Jean Romuald Ernest; Carl R Fayette; Charles W Goss; Marisa Hast; Kobie O'Brian; Guy Emmanuel Pavilus; Daniel Frantz Sabin; Ryan E Wiegand; Gary J Weil; Jean Frantz Lemoine
Journal:  PLoS Negl Trop Dis       Date:  2020-06-08

10.  Results From 2 Cohort Studies in Central Africa Show That Clearance of Wuchereria bancrofti Infection After Repeated Rounds of Mass Drug Administration With Albendazole Alone Is Closely Linked to Individual Adherence.

Authors:  Jérémy T Campillo; Naomi P Awaca-Uvon; Francois Missamou; Jean-Paul Tambwe; Godefroy Kuyangisa-Simuna; Gary J Weil; Frédéric Louya; Michel Boussinesq; Sébastien D S Pion; Cédric B Chesnais
Journal:  Clin Infect Dis       Date:  2021-07-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.